BREAKTHROUGH Medicine FDA approved 9/11/23
Aphexdra (motixafortide) has been approved by the FDA and is the FIRST
innovation in ten years for multiple myeloma patients. This novel medicine
is to be used in combination with Filgrastim (G-CSF) to mobilize crucial
Stem Cells for collection and Subsequent patient transplant (Autologous) in
people with Multiple Myeloma.
Multiple myeloma (MM) is a cancer of the blood that does NOT have a cure.
This incurable cancer affects a crucial kind of white blood cell called a
plasma cell in the bone marrow. In MM patients, these abnormal plasma cells
spread and replace normal cells and this diagnosis happens in more than
35,000 in the US. Nearly 13,000 patients die from MM each year (Click hereto read more).
Join our email list
get new video updates and be first to find out about upcoming sales!
What’s Coming next
Summer is moving by quickly and we have all unfortunately learned how to deal with historically high temperatures. Staying hydrated and replacing electrolytes is something you've probably gotten tired of. September is Healthy Aging month--I'll be creating a new video on what an Age-Friendly health system is so you can give your local system a check up. Did you know that September is also National Cholesterol Education month and World Alzheimer's month? We have a lot to know and learn and fortunately there are better medicines and some good news that we will share!
October is National breast cancer awareness month as well as ADHD awareness month. I have some family experience with both problems and I hope to bring important pillars of how my family dealt with health challenges that may give you a starting point on how to talk to your doctor from a framework of what's next. More to follow and update as always. Thank you for all your support and good will.